Trials / Completed
CompletedNCT01813487
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy in Patients Who Have Been Treated With HB110E Hepatitis B DNA Vaccine
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Genexine, Inc. · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the immunogenicity and efficacy of HBsAg Vaccine in combination with Entecavir in patients who have been treated with HB110E HBV DNA vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HBsAg vaccine with Entecavir |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-03-19
- Last updated
- 2013-12-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01813487. Inclusion in this directory is not an endorsement.